Pyridine-containing compound metabolic process

pathway activity — cross-omics
GO:0072524Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyridine-containing compound metabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are GPD1, EPB41L3, and DOCK2_S1592, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyridine-containing compound metabolic process activity versus GPD1 in GBM (Pearson r = 0.38).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMGPD1 →+0.683+0.028<.001<.00136
GBMEPB41L3 →+0.688+0.046<.001<.00136
PDACDOCK2_S1592 →+0.418+0.021<.001<.00135
UCECINPP5D_S971 →+0.383+0.038.006.00135
OVPLIN5_S140 →+1.483+0.042.007.00135
BRCARCSD1 →+0.424+0.019<.001.00335
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072524 vs GPD1 — GBM

Per-sample scatter of Pyridine-containing compound metabolic process activity vs GPD1 in GBM.

Explore this scatter interactively →

Exploration